BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li WJ, Archontakis-Barakakis P, Palaiodimos L, Kalaitzoglou D, Tzelves L, Manolopoulos A, Wang YC, Giannopoulos S, Faillace R, Kokkinidis DG. Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis. World J Cardiol 2021; 13(4): 82-94 [PMID: 33968307 DOI: 10.4330/wjc.v13.i4.82]
URL: https://www.wjgnet.com/1949-8462/full/v13/i4/82.htm
Number Citing Articles
1
Maurizio Giuseppe Abrignani, Alberto Lombardo, Annabella Braschi, Nicolò Renda, Vincenzo Abrignani, Renzo M Lombardo. Time trends in antithrombotic therapy prescription patterns: Real-world monocentric study in hospitalized patients with atrial fibrillationWorld Journal of Cardiology 2022; 14(11): 576-598 doi: 10.4330/wjc.v14.i11.576
2
Paraschos Archontakis‐Barakakis, Weijia Li, Dimitrios Kalaitzoglou, Lazaros Tzelves, Apostolos Manolopoulos, Stefanos Giannopoulos, Grigorios Giamouzis, George Giannakoulas, Apostolos Batsidis, Leonidas Palaiodimos, George Ntaios, Gregory Y. H. Lip, Damianos G. Kokkinidis. Effectiveness and safety of intracranial events associated with the use of direct oral anticoagulants for atrial fibrillation: A systematic review and meta‐analysis of 92 studiesBritish Journal of Clinical Pharmacology 2022; 88(11): 4663 doi: 10.1111/bcp.15464
3
Paraschos Archontakis Barakakis, Damianos G. Kokkinidis, Weijia Li, Sanjana Nagraj, Spyros Peppas, Michail Kladas, Dimitrios Schizas, Panagiotis Korantzopoulos, George Ntaios. Safety of Direct Oral Anticoagulants for Gastrointestinal Hemorrhage in Patients With Nonvalvular Atrial FibrillationJournal of Clinical Gastroenterology 2023; 57(10): 1045 doi: 10.1097/MCG.0000000000001796